Oncternal Therapeutics, Inc. (ONCT) has a market capitalization of $1.56M and trades at $0.53. The 52-week range is 0.5266-10.613.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-13.43, annual revenue of $785K.
The stock has a beta of 1.36, operates in the Healthcare sector.
